Intestinal side-effects of docetaxel/vinorelbine combination

Lancet. 2000 Mar 25;355(9209):1098-9. doi: 10.1016/S0140-6736(05)72219-4.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase II
  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents, Phytogenic / administration & dosage
  • Antineoplastic Agents, Phytogenic / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Breast Neoplasms / drug therapy*
  • Docetaxel
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Female
  • Gastroenteritis / chemically induced*
  • Humans
  • Neutropenia / chemically induced
  • Paclitaxel / administration & dosage
  • Paclitaxel / adverse effects
  • Paclitaxel / analogs & derivatives*
  • Risk Factors
  • Taxoids*
  • Vinblastine / administration & dosage
  • Vinblastine / adverse effects
  • Vinblastine / analogs & derivatives*
  • Vinorelbine

Substances

  • Antineoplastic Agents, Phytogenic
  • Taxoids
  • Docetaxel
  • Vinblastine
  • Paclitaxel
  • Vinorelbine